Transdermal Drug Delivery Systems Market 2018 Global Industry Size, Share, Growth, Trends, Company Profiles And 2023 Future Market Analysis
The detailed report of Transdermal Drug Delivery Systems Market evaluated by skilled experts is segmented into Application and Product. The Transdermal Drug Delivery Systems Market is anticipated to witness considerable development in the following years from 2018-2023.
Industry Outlook and Trend Analysis:
The global Transdermal Drug Delivery Systems market was worth USD 29.45 billion in 2014 and is expected to reach approximately USD 67.61 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.67% during the forecast period. Transdermal drug delivery systems are a substitution to oral subcutaneous, intravascular, and transmucosal courses, wherein the medications are given through the skin for therapeutic use. Ascend in aged populace and upsurge in number of patients experiencing incessant scatters are foreseen to drive the market development. In addition, rising implementation of third-generation transdermal drug delivery systems, for example, iontophoresis, supports the market development. Nonetheless, inconveniences of these delivery systems, for example, irritation at the site of usage and edema, are anticipated to obstruct the market development.
Major Key Players:
The leading players in the market are Endo International plc, GlaxoSmithKline, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Endo International plc, Echo Therapeutics Inc, Acrux and Mylan.
Market Segmentation:
The global transdermal drug delivery systems market is fragmented based on type of delivery system and application. On the basis of type, it is grouped into active and passive delivery systems. The passive delivery systems are additionally divided into reservoir system and matrix system. Active delivery systems are sorted into structure based, electrical based and others. By application, it is separated into hormone replacement therapy, motion sickness, smoking cessation, analgesics, cardiovascular disorders, and others.
Regional Outlook and Trend Analysis:
Asia-Pacific offers lucrative opportunities for the market development, attributable to existence of vast pool of patients experiencing chronic disorders, for example, hypertension. As indicated by a CADI Research Foundation, hypertension is the most common ailment in India. It is apparent from the way that the quantity of individuals with hypertension is anticipated to increment to 214 million out of 2025 from 118 million in 2000. Thus, high occurrence of cardiovascular disorders, for example, hypertension, makes it a lucrative business sector for transdermal drug delivery systems.
Drivers and Restraints:
Upsurge in the frequency of disorders, for example, Parkinson's disease, and increment in aged populace have prompted high adoption of transdermaldrug delivery systems. Moreover, advent of innovative treatment procedures, for example, third-generation transdermal drug delivery systems (microneedles), has additionally prompted the market growth. The market has encountered improvement of new adhesives, penetration enhancers, and molecular absorption enhancers that are foreseen to upgrade skin porousness, bringing about development of the scope of medications that are required to be given through transdermal course.
Major Table of Contents:
Part 1. Introduction
1.1. Report Description
1.2. Research Methodology
Part 2. Executive Summary
2.1. Key Highlights
Part 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increasing Prevalence of Chronic Disorders
3.2.1.2. Rise in Adoption of Third-Generation Delivery Systems
3.2.2. Restraints
3.2.2.1. Side-effects of the systems
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
....CONTINUED FOR TOC
(Early buyers will receive 10% customization on this report.)
Make an Enquiry Of report for Discount at: https://www.crystalmarketresearch.com/check-discount/HC01509 .
About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.